Abstract 15615: Eligibility for Lipid Lowering Therapy Based on AHA/ACC Risk Score, Coronary Artery Calcification, and CVD Events- National Implications for the Appropriate Use of Preventive Pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA)